NCT07709000
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07709000
Title A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)
Acronym MK-1045-006
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries ISR


No variant requirements are available.